Free delivery on orders of 500 zł or more in Poland Products with HPLC quality certificates Dispatched within 24 hours Free delivery on orders of 500 zł or more in Poland Products with HPLC quality certificates Dispatched within 24 hours

Triple G 12 mg

Delivery time

1-2 working days

quality assurance

Chemical reagent

CAS: 2381089-83-2 

4.9/5.00 - 236 opinions
Rating: 4.6 out of 5

Price: 649,00 579.00 zł

-10% for a second product
-20% for the fourth product

Product temporarily out of stock

Retatrutide – reagent, characteristics

Retatrutide (LY3437943) is a synthetic peptide for research use, characterised by a modified amino acid sequence. In the scientific literature, it is described as a triple agonist of the GLP-1, GIP and glucagon receptors (GCGR). From a chemical and functional perspective, it is an advanced research compound designed to simultaneously activate several key metabolic pathways. Compared with peptides such as tirzepatyd or semaglutide, retatrutide exhibits a broader receptor profile, including an additional glucagon receptor, and therefore remains an important target for research into glucose metabolism, energy balance and lipid metabolism.

The functional structure of retatrutide has been designed to enhance metabolic stability and prolong the molecule’s duration of action, which is significant in studies of long-term modulation of metabolic processes. For this reason, Triple G can be described as a research material intended for laboratory use, including as a reference standard and analytical material in quality control procedures and instrumental analyses, such as HPLC.


Mechanism of retatrutide receptor interaction

According to the results of preclinical and clinical studies, retatrutide acts as a triple agonist of the GLP-1, GIP and GCGR receptors, influencing the regulation of appetite, glucose metabolism and energy expenditure. Activation of the GLP-1 and GIP pathways is associated with improved glycaemic control and reduced energy intake, whilst the role of the glucagon receptor is being investigated in relation to increased energy expenditure and lipid metabolism. Clinical trials have also reported improvements in glycaemic parameters, including HbA1c, and favourable changes in selected metabolic markers.

More recent analyses of retatrutide also indicate that the observed changes in body composition largely involved a reduction in body fat with relative maintenance of lean mass. Therefore, retatrutide remains one of the more advanced research peptides analysed in the area of metabolic endocrinology, body weight control and energy balance.

See also Triple G reagent in 8 mg in a pen-type dosing device


The use of retatrutide in laboratory procedures

Retatrutide can be described as an RUO research reagent used in analyses on incretin signalling, glucose metabolism, energy balance and lipid metabolism. The molecule can act as a reference material in comparative studies, stability tests, qualitative analyses and instrumental procedures such as HPLC. Due to its triple receptor profile, it remains a particularly interesting compound for research projects involving complex metabolic mechanisms.


Scientific sources:

  1. PubMed ID (PMID): 37366315 Jastreboff A.M. et al.
  2. PubMed ID (PMID): 38323122 Naeem M. et al.
  3. PubMed ID (PMID): 37385280 - retatrutide clinical trials
  4. PubMed ID (PMID): 40609566

Triple G 12 mg (Retatrutide) w fiolce | Wysokiej czystości odczynnik chemiczny

The product is intended for scientific research and laboratory analysis. All articles and information on this website are for informational and educational purposes only.

Preview of quality studies

Download the safety data sheet

Download instructions for use

ParameterValue
Product nameTriple G 12 mg vial
Catalogue number3862749-12-04
CAS number2381089-83-2
BrandNovell
CategoryTest compound/chemical reagent
Molecular targetGLP-1 / GIP / GCGR receptors
Sequencemodified research peptide; sequence as per batch specification / COA
Summary formulaC221H342N46O68
Molar massapprox. 4731.33 g/mol
Cleanliness≥99% HPLC / according to batch COA
Confirmation of identityMS mass spectrometry / HPLC analysis / batch COA
Formlyophilised powder in a vial
Unit quantityEach vial contains 12 mg of the test compound. Quantity adapted for multiple laboratory tests and comparative analyses.
Concentrationaccording to batch / COA specifications
Buffer/Carriernot applicable - lyophilised form
pH of the solutionaccording to batch COA / not applicable for dry form
Storage conditionsStore in a cool, dry and shaded place. After opening or reconstitution, store in the refrigerator and protect from light.
Stability after openingaccording to laboratory protocol/batch COA
COA per batchcertificate of analysis available for each batch of product
Applicationexclusively for laboratory tests, reference analyses and research-grade applications
Important informationThis product is classified as a chemical reagent intended solely for scientific research, laboratory analysis and reference purposes. It is not a medicinal product, a food supplement or a foodstuff. It is not intended for use, administration or consumption by humans or animals, nor for diagnostic or therapeutic purposes. The purchaser is obliged to use the product in accordance with its intended purpose, applicable regulations and relevant laboratory procedures. The seller shall not be liable for the consequences of using the product contrary to its declared purpose, subject to mandatory provisions of law.

14 day return policy

LAboratory quality

Safe shopping

Opinions

Add a review
Novell - odczynniki peptydowe Novell – peptide reagents
Rating*
0/5
* Rating is required
Your review
* Review is required
Name
.
* Name is required
4.9
Based on 262 reviews
5
89
89%
4
9
9%
3
2
2%
2
0
0%
<